Cargando…

Editorial: Women in pharmacology of anti-cancer drugs: 2021

Detalles Bibliográficos
Autor principal: Giovannetti, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748683/
https://www.ncbi.nlm.nih.gov/pubmed/36532781
http://dx.doi.org/10.3389/fphar.2022.1092204
_version_ 1784849876315537408
author Giovannetti, Elisa
author_facet Giovannetti, Elisa
author_sort Giovannetti, Elisa
collection PubMed
description
format Online
Article
Text
id pubmed-9748683
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97486832022-12-15 Editorial: Women in pharmacology of anti-cancer drugs: 2021 Giovannetti, Elisa Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9748683/ /pubmed/36532781 http://dx.doi.org/10.3389/fphar.2022.1092204 Text en Copyright © 2022 Giovannetti. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Giovannetti, Elisa
Editorial: Women in pharmacology of anti-cancer drugs: 2021
title Editorial: Women in pharmacology of anti-cancer drugs: 2021
title_full Editorial: Women in pharmacology of anti-cancer drugs: 2021
title_fullStr Editorial: Women in pharmacology of anti-cancer drugs: 2021
title_full_unstemmed Editorial: Women in pharmacology of anti-cancer drugs: 2021
title_short Editorial: Women in pharmacology of anti-cancer drugs: 2021
title_sort editorial: women in pharmacology of anti-cancer drugs: 2021
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748683/
https://www.ncbi.nlm.nih.gov/pubmed/36532781
http://dx.doi.org/10.3389/fphar.2022.1092204
work_keys_str_mv AT giovannettielisa editorialwomeninpharmacologyofanticancerdrugs2021